Clinical trial
Clinical Study Evaluating Mebendazole as Adjuvant Therapy in Patients With Colorectal Cancer
NCT03925662 is registered in ClinicalTrials.gov with Sherief Abd-Elsalam as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study Evaluating Mebendazole as Adjuvant Therapy in Patients With Colorectal Cancer
- Lead sponsor
- Sherief Abd-Elsalam
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- April 1, 2019
- Completion date
- December 31, 2028
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer